Bacil Pharma Limited (BOM:524516)

Bacil Pharma Statistics

Total Valuation

Bacil Pharma has a market cap or net worth of INR 529.63 million. The enterprise value is 502.69 million.

Market Cap	529.63M
Enterprise Value	502.69M

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date	Aug 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Bacil Pharma has 14.35 million shares outstanding. The number of shares has increased by 34.82% in one year.

Current Share Class	14.35M
Shares Outstanding	14.35M
Shares Change (YoY)	+34.82%
Shares Change (QoQ)	+78.61%
Owned by Insiders (%)	7.45%
Owned by Institutions (%)	n/a
Float	12.46M

Valuation Ratios

The trailing PE ratio is 26.41.

PE Ratio	26.41
Forward PE	n/a
PS Ratio	n/a
PB Ratio	2.08
P/TBV Ratio	2.08
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	45.42
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-1.48%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	n/a
Profits Per Employee	3.69M
Employee Count	3
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Bacil Pharma has paid 2.28 million in taxes.

Income Tax	2.28M
Effective Tax Rate	17.10%

Stock Price Statistics

The stock price has increased by +131.78% in the last 52 weeks. The beta is 0.30, so Bacil Pharma's price volatility has been lower than the market average.

Beta (5Y)	0.30
52-Week Price Change	+131.78%
50-Day Moving Average	40.27
200-Day Moving Average	37.36
Relative Strength Index (RSI)	40.74
Average Volume (20 Days)	19,448

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-3.18M
Pretax Income	13.35M
Net Income	11.07M
EBITDA	-3.18M
EBIT	-3.18M
Earnings Per Share (EPS)	1.40

Balance Sheet

The company has 28.57 million in cash and 1.64 million in debt, giving a net cash position of 26.93 million or 1.88 per share.

Cash & Cash Equivalents	28.57M
Total Debt	1.64M
Net Cash	26.93M
Net Cash Per Share	1.88
Equity (Book Value)	254.31M
Book Value Per Share	32.60
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Bacil Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.82%
Shareholder Yield	n/a
Earnings Yield	2.09%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1